Mary Ann Liebert, Inc., has announced the appointment of Dr. Cory Brooks as the new Editor-in-Chief of the bimonthly journal Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. Dr. Brooks is succeeding Dr. Thomas Kieber-Emmons.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy provides authoritative, peer-reviewed research on the development of new genetic testing technologies and the ethical, legal, social, and economic issues associated with genetic testing. It is the leading peer-reviewed journal covering all aspects of human genetic testing including molecular biomarkers.
Dr. Cory Brooks is a Professor in the Department of Chemistry and Biochemistry at California State University Fresno. His research has particular emphasis on nano-bodies and antibody carbohydrate interactions. Dr. Brooks has co-authored more than 40 publications, and holds grants from the National Cancer Institute of the NIH, CSUBIOTECH, as well as private research contracts from antibody biotechnology companies.
Click here to read the original press release.
